EVO

Evotec SE ADR

May 15 • 04:00PM ET

2.70

-0.02 -0.74 %

Healthcare • Drug Manufacturers - Specialty & Generic • Germany • Small • NASD

Index	-	P/E	-	EPS (ttm)	-0.63	Insider Own	5.17%	Shs Outstand	355.18M	Perf Week	-12.05%
Market Cap	958.99M	Forward P/E	-	EPS next Y	-0.07	Insider Trans	0.00%	Shs Float	336.81M	Perf Month	-16.15%
Enterprise Value	892.96M	PEG	-	EPS next Q	0.01	Inst Own	1.46%	Short Float	0.03%	Perf Quarter	-23.08%
Income	-225.27M	P/S	1.11	EPS this Y	-15.70%	Inst Trans	-51.79%	Short Ratio	0.72	Perf Half Y	-14.01%
Sales	863.66M	P/B	1.19	EPS next Y	82.87%	ROA	-11.29%	Short Interest	0.09M	Perf YTD	-12.34%
Book/sh	2.27	P/C	1.87	EPS next 5Y	-	ROE	-25.15%	52W High	4.80 -43.75%	Perf Year	-31.47%
Cash/sh	1.44	P/FCF	-	EPS past 3/5Y	14.30% -	ROIC	-19.58%	52W Low	2.31 16.98%	Perf 3Y	-75.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	4.05% 9.27%	Gross Margin	11.48%	Volatility	2.85% 3.55%	Perf 5Y	-86.58%
Dividend TTM	-	EV/Sales	1.03	EPS Y/Y TTM	-1.13%	Oper. Margin	-16.56%	ATR (14)	0.14	Perf 10Y	25.29%
Dividend Ex-Date	Jan 11, 2019	Quick Ratio	1.60	Sales Y/Y TTM	2.13%	Profit Margin	-26.08%	RSI (14)	37.19	Recom	2.20
Dividend Gr. 3/5Y	- -	Current Ratio	1.68	EPS Q/Q	-329.17%	SMA20	-11.76%	Beta	1.92	Target Price	3.99
Payout	-	Debt/Eq	0.55	Sales Q/Q	-12.93%	SMA50	-3.73%	Rel Volume	0.36	Prev Close	2.72
Employees	4553	LT Debt/Eq	0.43	Earnings	May 06 BMO	SMA200	-19.12%	Avg Volume	120.18K	Price	2.70
IPO	Feb 05, 2004	Option/Short	No / Yes	EPS/Sales Surpr.	-181.47% -9.83%	Trades		Volume	43,545	Change	-0.74%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-15-26	Resumed	H.C. Wainwright	Buy	$7
Feb-03-26	Initiated	Berenberg	Buy
Apr-24-25	Upgrade	Deutsche Bank	Sell → Hold
Oct-07-24	Downgrade	Jefferies	Buy → Hold
Aug-08-24	Downgrade	Deutsche Bank	Hold → Sell
Jul-29-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$15 → $6
Jul-11-24	Downgrade	Deutsche Bank	Buy → Hold
Apr-12-24	Upgrade	Deutsche Bank	Hold → Buy
Jan-18-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Jun-23-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$12 → $16
Jun-16-23	Downgrade	BofA Securities	Buy → Neutral	$13
Jun-08-23	Upgrade	Citigroup	Neutral → Buy
Apr-04-23	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$11 → $12
Dec-09-22	Initiated	H.C. Wainwright	Buy	$12
Nov-16-22	Downgrade	Deutsche Bank	Buy → Hold
Aug-10-22	Downgrade	Morgan Stanley	Overweight → Underweight	$23 → $16
Mar-02-22	Resumed	Cowen	Outperform
Jan-07-22	Resumed	Citigroup	Neutral

Show Previous Ratings

May-12-26 05:15PM	Evotec SE Successfully Placed 116.1 Million Convertible Bonds (ACCESSWIRE) -9.50%
May-04-26 01:50AM	Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall (ACCESSWIRE)
Apr-30-26 03:20AM	Evotec Receives Grants to Advance Tuberculosis Treatment (ACCESSWIRE) +5.78%
Apr-29-26 04:45PM	Evotec Announces New Nomination to Board of Directors (ACCESSWIRE)
01:50AM	Evotec SE to Announce First Quarter 2026 Results on May 6, 2026 (ACCESSWIRE)
01:50AM	Loading…
Apr-24-26 01:50AM	Evotec Announces Chief Financial Officer Transition (ACCESSWIRE)
Apr-15-26 01:50AM	Evotec Appoints Dr. Ingrid Muller as Chief Operating Officer (ACCESSWIRE)
Apr-08-26 03:00PM	Evotec SE (EVOTF) Q4 2025 Earnings Call Highlights: Strategic Gains Amid Revenue Challenges (GuruFocus.com)
05:33AM	Delta Air Lines heads earnings slate (MarketWatch)
Apr-07-26 09:16AM	What To Expect From Evotec SE (XTER:EVT) Q4 2025 Earnings (GuruFocus.com)
03:00AM	Evotec Nominates Dieter Weinand as Supervisory Board Chairman (ACCESSWIRE)
Apr-01-26 05:35AM	Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026 (ACCESSWIRE)
01:50AM	Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer (ACCESSWIRE)
Mar-23-26 03:10AM	Just - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses (ACCESSWIRE)
Mar-19-26 02:50AM	Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation (ACCESSWIRE)
06:17AM	Loading…
Mar-13-26 06:17AM	Evotec, Vistagen lay off staff; Immutep shares collapse on study failure (BioPharma Dive)
Mar-10-26 02:27PM	Evotec Restructuring Aims To Improve Profitability After Transition Year (Benzinga) -11.88%
07:10AM	Solvonis Therapeutics CEO on SVN-114 and PTSD market opportunity (Proactive)
Jan-18-26 12:30PM	Is Evotec SE (EVO) One of the Best Debt-Free Penny Stocks to Buy Right Now? (Insider Monkey)
Jan-08-26 01:50AM	Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access (ACCESSWIRE)
Jan-02-26 12:30AM	Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations (ACCESSWIRE)
Dec-08-25 01:20AM	Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz (ACCESSWIRE)
Dec-04-25 02:50AM	Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome (ACCESSWIRE)
Nov-12-25 02:00AM	Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership (ACCESSWIRE) +5.72%
Nov-05-25 02:00AM	Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities (ACCESSWIRE) -15.74%
Nov-04-25 04:30PM	In A Landmark Industry Transaction, Evotec Signs Agreement With Sandoz, Resulting In Payments Potentially Over US $650 M Plus Royalties (ACCESSWIRE)
07:59AM	Earnings To Watch: Evotec SE (EVO) Reports Q3 2025 Result (GuruFocus.com)
Oct-29-25 05:10AM	Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025 (ACCESSWIRE)
Oct-27-25 02:50AM	Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb (ACCESSWIRE)
Oct-17-25 11:52AM	ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up (Zacks)
05:29PM	Loading…
Aug-26-25 05:29PM	Analyst Report: Evotec SE (Morningstar Research)
Aug-14-25 02:41AM	Analyst Report: Evotec SE (Morningstar Research)
Aug-13-25 01:25AM	Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution (ACCESSWIRE)
Aug-12-25 09:24AM	Evotec SE (EVO) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Aug-06-25 04:15AM	Evotec SE to announce first half-year results 2025 on 13 August 2025 (ACCESSWIRE)
Aug-04-25 08:17PM	Analyst Report: Evotec SE (Morningstar Research)
Jul-30-25 01:45AM	Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site (ACCESSWIRE)
01:40AM	Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site (ACCESSWIRE)
Jul-25-25 10:57PM	Analyst Report: Evotec SE (Morningstar Research) +5.19%
Jul-22-25 08:39PM	Analyst Report: Evotec SE (Morningstar Research)
09:09AM	Morning Movers: Cleveland-Cliffs rallies after second quarter earnings release (TipRanks)
Jul-21-25 07:28PM	Analyst Report: Evotec SE (Morningstar Research) -13.38%
06:10AM	Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix (ACCESSWIRE)
05:50AM	Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance (ACCESSWIRE)
Jul-18-25 08:34PM	Analyst Report: Evotec SE (Morningstar Research)
Jul-11-25 08:14PM	Analyst Report: Evotec SE (Morningstar Research)
Jul-09-25 10:31AM	Here Is What You Need To Know Before Investing In Evotec SE (EVO) (Insider Monkey)
Jul-02-25 07:42PM	Analyst Report: Evotec SE (Morningstar Research)
Jun-25-25 01:50AM	Evotec Joins NURTuRE-AKI Consortium to Gain Multi-Omics-Based Molecular Understanding of Acute Kidney Injury (ACCESSWIRE)
Jun-20-25 07:19PM	Analyst Report: Evotec SE (Morningstar Research) -5.29%
Jun-11-25 08:30PM	Analyst Report: Evotec SE (Morningstar Research)
Jun-03-25 05:28PM	Evotec SE: Results of the Annual General Meeting 2025 (NewMediaWire)
May-29-25 08:31PM	Analyst Report: Evotec SE (Morningstar Research) +5.03%
May-23-25 07:31PM	Analyst Report: Evotec SE (Morningstar Research) +17.37% -9.62%
May-15-25 08:26PM	Analyst Report: Evotec SE (Morningstar Research)
May-09-25 08:42PM	Analyst Report: Evotec SE (Morningstar Research) +9.97%
May-08-25 08:43PM	Analyst Report: Evotec SE (Morningstar Research) -6.24%
May-07-25 01:50AM	Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments (ACCESSWIRE)
01:43AM	Analyst Report: Evotec SE (Morningstar Research)
May-06-25 01:20AM	Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment (ACCESSWIRE)
Apr-29-25 04:30AM	Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025 (ACCESSWIRE)
Apr-28-25 07:25PM	Analyst Report: Evotec SE (Morningstar Research)
Apr-24-25 01:50AM	Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb (ACCESSWIRE)
Apr-17-25 03:58PM	Analyst Report: Evotec SE (Morningstar Research) +10.09%
02:24PM	Evotec SE (EVO) Q4 2024 Earnings Call Transcript (Seeking Alpha)
01:45AM	Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results (ACCESSWIRE)
Apr-10-25 06:00AM	Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025 (ACCESSWIRE) -5.85%
Apr-02-25 03:30PM	Is Evotec (EVO) the Best German Stock to Buy According to Hedge Funds? (Insider Monkey)
Mar-06-25 07:55PM	Analyst Report: Evotec SE (Morningstar Research) -5.66%
Mar-04-25 01:45AM	Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb (ACCESSWIRE) -6.89%
Feb-26-25 02:00AM	Evotec Announces Change in Management Board (ACCESSWIRE)
Jan-22-25 02:00AM	Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases (ACCESSWIRE)
Dec-11-24 02:00AM	Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk (ACCESSWIRE)
Nov-29-24 02:00AM	Evotec Announces Change in Management Board (ACCESSWIRE)
Nov-24-24 05:49PM	Analyst Report: Evotec SE (Morningstar Research)
Nov-22-24 11:15AM	Comment on Withdrawn Non-Binding Offer (ACCESSWIRE) -16.07%
08:35AM	Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions (PR Newswire)
Nov-20-24 12:14AM	Analyst Report: Evotec SE (Morningstar Research)
Nov-19-24 06:01PM	Is Evotec SE (EVO) the Best German Stock to Buy Now? (Insider Monkey) -7.21%
Nov-18-24 07:47PM	Analyst Report: Evotec SE (Morningstar Research)
07:00AM	Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec (PR Newswire)
Nov-15-24 10:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research) +6.67%
03:43PM	Analyst Report: Evotec SE (Morningstar Research)
Nov-14-24 05:30PM	Comment on Media Report (ACCESSWIRE) +12.09%
04:15PM	Halozyme Confirms Proposal to Combine with Evotec for 11.00 Per Share in an All-Cash Transaction (PR Newswire)
Nov-07-24 08:37AM	Analyst Report: Evotec SE (Morningstar Research) +9.96%
Nov-06-24 01:20AM	Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions (ACCESSWIRE) -15.61%
Nov-05-24 01:50AM	Evotec Announces Sale of API Manufacturing Facility to Monacum Partners (ACCESSWIRE)
Nov-04-24 07:18PM	Analyst Report: Evotec SE (Morningstar Research) +13.40%
Oct-30-24 03:30AM	Evotec SE to Announce Results for the First Nine Months 2024 on 06 November 2024 (ACCESSWIRE)
Oct-23-24 02:00AM	Evotec and Bristol Myers Squibb Expand Proteomics Partnership (ACCESSWIRE) +8.56%
Sep-26-24 02:00AM	Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies (ACCESSWIRE)
Sep-20-24 09:45AM	Just - Evotec Biologics Opens Cutting-Edge Biologics Facility - J.POD(R) Toulouse, France (EU) (ACCESSWIRE) -6.87%
Sep-05-24 08:00AM	Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery (Business Wire)
Sep-03-24 01:50AM	Evotec Announces Change in Management Board (ACCESSWIRE) -8.49%
Aug-14-24 10:09PM	Analyst Report: Evotec SE (Morningstar Research)
01:30AM	Evotec SE Reports H1 2024 Results: Challenging Year; Priority Reset for Sustainable Profitable Growth Gaining Momentum, Building on Core Strengths (ACCESSWIRE)
Aug-13-24 02:00AM	Evotec Announces Strong Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb (ACCESSWIRE) +11.78%
Aug-09-24 10:24AM	Analyst Report: Evotec SE (Morningstar Research)
Aug-08-24 01:50AM	Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb (ACCESSWIRE)

Evotec SE is a life science company, which engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the Shared R&D and Just-Evotec Biologics segments. The Shared R&D segment includes drug discovery and development services and solutions. The Just-Evotec Biologics segment provides services related to designing, discovering, developing, and manufacturing of modern biotherapeutics. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, Charles Weissmann, and Nobel Laureate on December 8, 1993 and is headquartered in Hamburg, Germany.

CEO & Chairperson of the Management BoardDr. Christian Wojczewski Ph.D.

Chief Scientific Officer & Member of Management BoardDr. Cord Dohrmann Ph.D.

Chief People Officer & Member of Management BoardMs. Aurelie Dalbiez

CFO & Member of Management BoardMs. Claire Hinshelwood

COO & Member of Management BoardDr. Ingrid Mller

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EVO

Evotec SE ADR

Upgrade your Finviz experience